Form D · Biotechnology
Artimplant AB
Vastra Frolunda, V7 · CIK 0001505186
Offering snapshot reported Mar 28, 2012 · SEC filing
- Reported sold
- $232K Offering amount: $232K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Mar 12, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 28, 2012 | Initial | $231,949 | No comparison | 2 | SEC filing |
| Nov 9, 2010 | Initial | $308,366 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-175708
This filing covers the purchase and sale of units consisting of Series B shares and warrants to purchase Series B shares and the underlying shares upon conversion of such warrants.
Source: Form D, filed Mar 28, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Arnold | Director |
| Rickard Branemark | Director |
| Anders Cedronius | Director |
| Hakan Johansson | Director |
| Lars Peterson | Director |
| Hans Rosen | Executive |
| Kjell Thornbring | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Hulda Mellgrens Gata5
Vastra Frolunda, V7, SE-421 32
Vastra Frolunda, V7, SE-421 32